This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Alector +2.08%
CrowdStrike -3.97%
Dianthus Therapeutics, Inc. -2.06%
Rivian Automotive +1.25%
SolarEdge Technologies, Inc. -0.19%
Alector ALEC | 2.45 | +2.08% |
CrowdStrike CRWD | 379.02 | -3.97% |
Dianthus Therapeutics, Inc. DNTH | 89.77 | -2.06% |
Rivian Automotive RIVN | 15.43 | +1.25% |
SolarEdge Technologies, Inc. SEDG | 41.76 | -0.19% |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Keith Weiss upgraded CrowdStrike Holdings (NASDAQ:CRWD) from Equal-Weight to Overweight and raised the price target from $487 to $510. CrowdStrike shares closed at $434.13 on Monday. See how other analysts view this stock.
- BTIG analyst Thomas Shrader upgraded Alector Inc (NASDAQ:ALEC) from Neutral to Buy and announced a $6 price target. Alector shares closed at $2.19 on Monday. See how other analysts view this stock.
- TD Cowen analyst Itay Michaeli upgraded Rivian Automotive Inc (NASDAQ:RIVN) from Hold to Buy and raised the price target from $17 to $20. Rivian Automotive shares closed at $15.87 on Monday. See how other analysts view this stock.
- B of A Securities analyst Julien Dumoulin-Smith upgraded Solaredge Technologies Inc (NASDAQ:SEDG) from Underperform to Neutral and raised the price target from $17 to $40. SolarEdge shares closed at $34.59 on Monday. See how other analysts view this stock.
- Raymond James analyst Steven Seedhouse upgraded Dianthus Therapeutics Inc (NASDAQ:DNTH) from Outperform to Strong Buy and raised the price target from $63 to $123. Dianthus Therapeutics shares closed at $79.23 on Monday. See how other analysts view this stock.
Considering buying CRWD stock? Here’s what analysts think:
Photo via Shutterstock
